Medical Devices News

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River announced a collaboration with the U.S. FDA and Labcorp to develop screening tools to quantify and rank the abuse potential of new drugs...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced it will report business updates and financial results for the third quarter 2026 after market close on Thursday, November 5, 2026. Company management will host a corresponding conference call to discuss business updates beginning at 1:30pm PT / 4:30pm ET.Investors interested in l...

SAN DIEGO--(BUSINESS WIRE)--Nutromics has presented world-first, real-time measurements of creatinine in humans using DNA-based sensors at American Society of Nephrology’s (ASN) Kidney Week 2026. The data comes from healthy participants wearing the company’s Lab-on-a-Patch™ and supports early detection and quantification of changing renal function. The company has also further deployed this wearable patch in the ICU in Australian hospital-based clinical studies. DNA-based sensing is a platform...

CHICAGO--(BUSINESS WIRE)--VIOVOC, the first-of-its-kind ambient bathroom sensor that helps users master their gut health, has been issued a US patent...

CLICHY, France--(BUSINESS WIRE)--CorWave SA, a clinical-stage medical technology company pioneering innovative cardiac assist devices, announces the completion of enrollment in its feasibility study of the CorWave Left Ventricular Assist System (LVAS). The company also presented the first clinical data on the device's adaptive control algorithm at the 18th Branislav ‘BRANO’ Radovancevic Heart Failure Forum, held jointly with the 19th Innovations and New Treatment Strategies in Heart Failure sym...

CHICAGO & SÃO PAULO--(BUSINESS WIRE)--Contrast-enhanced ultrasound (CEUS) is “safe, cost-effective and widely-supported by scientific evidence,” according to new evidence-based guidelines on the use of microbubble contrast agents in cardiovascular ultrasound published by the Brazilian Society of Cardiology (DIC/SBC) with endorsement of the International Contrast Ultrasound Society (ICUS). The “Guideline on the Clinical Use of Ultrasound-Enhancing Agents in Cardiology Applications – 2026” suppor...

NEW YORK--(BUSINESS WIRE)--Sofusa Holdings today announced its launch as an independent, clinical-stage company pioneering the development of a proprietary nanotechnology platform for precision targeting of lymphatic vessels and lymph nodes. The company has restarted manufacturing and plans to develop a pipeline of combination biologic products for autoimmune diseases, cancer and potentially other disorders of the immune system. In early human proof-of-concept clinical studies, the company’s Do...

DURHAM, N.C.--(BUSINESS WIRE)--Attendee-voted recognition highlights the Quantra® System’s relevance to trauma care....

GOLDEN, Colo.--(BUSINESS WIRE)--While supporting Pakistan since 2018, expansion into Afghanistan & Nigeria has helped PharmaJet reach this important milestone....

PALO ALTO, Calif.--(BUSINESS WIRE)--Tidepool, a non-profit leader advancing innovation in diabetes technology, today announced it has been awarded research funding from Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, to support clinical evaluation of an investigational “unannounced meal” feature for Tidepool Loop. First cleared by the Food and Drug Administration (FDA) in 2023, Tidepool Loop is an automated insulin dosing (AID) smartphone applicatio...